- Home
- PLSE vs NCDL Comparison
PLSE vs NCDL Comparison
Compare PLSE & NCDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLSE
- NCDL
- Stock Information
- Founded
- PLSE 2014
- NCDL 2019
- Country
- PLSE United States
- NCDL United States
- Employees
- PLSE N/A
- NCDL N/A
- Industry
- PLSE Medical/Dental Instruments
- NCDL
- Sector
- PLSE Health Care
- NCDL
- Exchange
- PLSE Nasdaq
- NCDL NYSE
- Market Cap
- PLSE 1.1B
- NCDL 814.1M
- IPO Year
- PLSE 2016
- NCDL N/A
- Fundamental
- Price
- PLSE $16.07
- NCDL $16.93
- Analyst Decision
- PLSE Buy
- NCDL Hold
- Analyst Count
- PLSE 1
- NCDL 4
- Target Price
- PLSE $22.00
- NCDL $16.31
- AVG Volume (30 Days)
- PLSE 202.2K
- NCDL 263.4K
- Earning Date
- PLSE 08-11-2025
- NCDL 08-06-2025
- Dividend Yield
- PLSE N/A
- NCDL 12.29%
- EPS Growth
- PLSE N/A
- NCDL N/A
- EPS
- PLSE N/A
- NCDL N/A
- Revenue
- PLSE N/A
- NCDL N/A
- Revenue This Year
- PLSE N/A
- NCDL N/A
- Revenue Next Year
- PLSE $700.00
- NCDL N/A
- P/E Ratio
- PLSE N/A
- NCDL N/A
- Revenue Growth
- PLSE N/A
- NCDL N/A
- 52 Week Low
- PLSE $13.50
- NCDL $14.21
- 52 Week High
- PLSE $25.00
- NCDL $18.01
- Technical
- Relative Strength Index (RSI)
- PLSE 51.09
- NCDL 65.59
- Support Level
- PLSE $15.19
- NCDL $16.42
- Resistance Level
- PLSE $17.27
- NCDL $16.78
- Average True Range (ATR)
- PLSE 0.76
- NCDL 0.29
- MACD
- PLSE 0.18
- NCDL 0.05
- Stochastic Oscillator
- PLSE 53.67
- NCDL 97.73
About PLSE Pulse Biosciences Inc (DE)
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled.
About NCDL NUVEEN CHURCHILL DIRECT LENDNG CORP
Nuveen Churchill Direct Lending Corp is a specialty finance company focused predominantly on investing in senior secured loans to private equity-owned U.S. middle market companies. It invest in senior secured loans that typically pay floating interest rates and are senior in the capital structure to junior debt and equity.